Editorial comment on "Maintenance bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials"

被引：0
|
作者：
Huang, Shu-Pin [1 ,2 ]
机构：
[1] Kaohsiung Med Univ Hosp, Dept Urol, 100 Tz You 1st Rd, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan
来源：
UROLOGICAL SCIENCE | 2015年 / 26卷 / 02期
关键词：
D O I：
10.1016/j.urols.2015.04.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / +
页数：2
相关论文
共 50 条
  • [31] Purified Protein Derivative Skin test prior to bacillus Calmette-Guerin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
    Svatek, Robert S.
    JOURNAL OF UROLOGY, 2018, 199 (06): : 1452 - 1452
  • [32] Bacillus Calmette-Guerin and bladder cancer
    Razack, Azad H. A.
    ASIAN JOURNAL OF SURGERY, 2007, 30 (04) : 302 - 309
  • [33] Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guerin Treatment Editorial Commentary
    Hussein, Ahmed A.
    Guru, Khurshid A.
    UROLOGY PRACTICE, 2018, 5 (02) : 138 - 138
  • [34] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
  • [35] The current landscape of salvage therapies for patients with bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer
    Packiam, Vignesh T.
    Richards, Jordan
    Schmautz, Maximilian
    Heidenreich, Axel
    Boorjian, Stephen A.
    CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 178 - 187
  • [36] The impact on survival outcomes of different Bacillus Calmette-Guerin strains of nonmuscle invasive bladder cancer patients
    Liu, K.
    Zhao, H.
    Chen, X.
    Chiu, P. K.
    Ng, C.
    Teoh, J. Y.
    EUROPEAN UROLOGY, 2023, 83 : S396 - S396
  • [37] Endovesical Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
    Prudhomme, Thomas
    Andras, Iulia
    Boissier, Romain
    Campi, Riccardo
    Hevia, Vital
    Territo, Angelo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 789 - 791
  • [38] Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guerin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
    Yokomizo, Akira
    Kanimoto, Yusuke
    Okamura, Takehiko
    Ozono, Seiichiro
    Koga, Hirofumi
    Iwamura, Masatsugu
    Tanaka, Hiroshi
    Takahashi, Satoru
    Tsushima, Tomoyasu
    Kanayama, Hiro-omi
    Akaza, Hideyuki
    Shinohara, Nobuo
    Mugiya, Soichi
    Nomata, Koichiro
    Nakamura, Tsuyoshi
    Naito, Seiji
    JOURNAL OF UROLOGY, 2016, 195 (01): : 41 - 46
  • [39] Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study
    Nishiyama, Naotaka
    Hotta, Hiroshi
    Takahashi, Atsushi
    Yanase, Masahiro
    Itoh, Naoki
    Tachiki, Hitoshi
    Miyao, Noriomi
    Matsukawa, Masanori
    Kunishima, Yasuharu
    Taguchi, Keisuke
    Kitamura, Hiroshi
    Masumori, Naoya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 306.e9 - 306.e15
  • [40] Impact of chronic kidney disease on prognosis in patients with high-risk nonmuscle-invasive bladder cancer who underwent adjuvant induction bacillus Calmette-Guerin therapy
    Fujita, N.
    Momota, M.
    Narita, T.
    Ito, H.
    Yoneyama, T.
    Hashimoto, Y.
    Yoshikawa, K.
    Ohyama, C.
    Hatakeyama, S.
    EUROPEAN UROLOGY, 2024, 85 : S1166 - S1167
12345